drugset / Trial / NCT01587391
Study to Investigate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Rising Doses of BI 163538 XX
RandomizedParallel-groupDouble-blindTreatment
Summary
To investigate safety, tolerability, pharmacokinetics including dose proportionality, and pharmacodynamics of BI 163538 XX within a predefined dose range
Timeline
- Start
- 2012-04
- Primary completion
- 2012-10
- Completion
- 2012-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | BI 163538 XX | Unknown | — | Oral |
Indications
No indication recorded.